It has been found that the infections caused by carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) are associated with greater threat to human health with high fatality rates and increased healthcare cost, compared to the infections caused by non-CP-CRE [3–6]. This evidence concerns the gene CP and infection.